NasdaqGS - Nasdaq Real Time Price USD

Medpace Holdings, Inc. (MEDP)

395.93 +6.16 (+1.58%)
At close: April 26 at 4:00 PM EDT
394.87 -1.06 (-0.27%)
After hours: April 26 at 4:49 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. August James Troendle M.D. Chairman & CEO 1.65M -- 1956
Mr. Jesse J. Geiger BBA, CPA President 945.08k -- 1974
Mr. Kevin M. Brady CFO & Treasurer 690.48k 1.64M 1975
Ms. Susan E. Burwig BSN, MA Executive Vice President of Operations 1.12M 1.47M 1963
Mr. Stephen P. Ewald J.D. Chief Compliance Officer, General Counsel & Corporate Secretary 914.64k 3.2M 1969
Brandon Ebken Chief Information Officer -- -- --
Ms. Lauren Morris Associate Director of Investors Relations -- -- --
Mr. Todd Meyers Vice President of Business Development & Marketing -- -- --
John T. Wynne MBA Senior Vice President of Commercial Operations & Clinical Pharmacology Unit -- -- --
Mr. Reinilde Heyrman M.D. Chief Medical Officer of Medical Department -- -- 1961

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911 https://www.medpace.com
Sector: 
Healthcare
Full Time Employees: 
5,800

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 7. The pillar scores are Audit: 4; Board: 10; Shareholder Rights: 8; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jul 22, 2024 - Jul 26, 2024
Medpace Holdings, Inc. Earnings Call

Related Tickers

TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
 
ICLR ICON Public Limited Company
308.31
+2.74%
 
DHR Danaher Corporation
246.58
+0.32%
 
IDXX IDEXX Laboratories, Inc.
499.30
+2.06%
 
IQV IQVIA Holdings Inc.
234.88
+0.38%
 
DGX Quest Diagnostics Incorporated
134.26
-0.86%
 
MTD Mettler-Toledo International Inc.
1,238.09
+0.42%
 
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
 
LH Laboratory Corporation of America Holdings
198.40
+0.03%
 
GH Guardant Health, Inc.
17.35
+1.11%